Quality of life and influencing factors of hematological malignancies treated with chimeric antigen receptor-T cell

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2200058072

Enrollment

Unknown

Registered

2022-03-28

Start date

2022-03-29

Completion date

Unknown

Last updated

2023-12-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hematological malignancies

Interventions

case series:None

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Aged >18 years; 2. Normal reading, expression and memory; 3. Patients understand their condition and are willing to participate in this study.

Exclusion criteria

Exclusion criteria: 1. Patients with mental illness or cognitive impairment; 2. Patients with other serious complications; 3. Patients with poor cooperation between themselves and their family members.

Design outcomes

Primary

Measure	Time frame
The European Organization for Research and Treatment of Cancer Quality of Life-Core 30;Social Support Rating Scale;	—

Countries

China

Contacts

Public ContactYan Jiali

675939382@qq.com+86 15168215759

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026